Cushing-Haugen KL - Search Results

1

Body mass index, weight, and oral contraceptive failure risk.

Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Holt VL, et al. Obstet Gynecol. 2005 Jan;105(1):46-52. doi: 10.1097/01.AOG.0000149155.11912.52. Obstet Gynecol. 2005. PMID: 15625141

2

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.

Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA. Malone KE, et al. Cancer. 2000 Mar 15;88(6):1393-402. doi: 10.1002/(sici)1097-0142(20000315)88:6<1393::aid-cncr17>3.0.co;2-p. Cancer. 2000. PMID: 10717622

3

Cimetidine use and risk of prostate and breast cancer.

Rossing MA, Scholes D, Cushing-Haugen KL, Voigt LF. Rossing MA, et al. Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):319-23. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10750671

4

Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.

Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, Wipf GC, Porter P, Daling JR, McDougall JK, Galloway DA. Carter JJ, et al. Cancer Res. 2001 Mar 1;61(5):1934-40. Cancer Res. 2001. PMID: 11280749

5

Body weight and risk of oral contraceptive failure.

Holt VL, Cushing-Haugen KL, Daling JR. Holt VL, et al. Obstet Gynecol. 2002 May;99(5 Pt 1):820-7. doi: 10.1016/s0029-7844(02)01939-7. Obstet Gynecol. 2002. PMID: 11978293

6

Human leukocyte antigen class II and cervical cancer risk: a population-based study.

Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, Nelson JL, Porter P, Shera KA, McDougall JK, Galloway DA. Madeleine MM, et al. J Infect Dis. 2002 Dec 1;186(11):1565-74. doi: 10.1086/345285. Epub 2002 Nov 4. J Infect Dis. 2002. PMID: 12447731

7

Hormone replacement therapy regimens and breast cancer risk(1).

Weiss LK, Burkman RT, Cushing-Haugen KL, Voigt LF, Simon MS, Daling JR, Norman SA, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Berlin JA, Weber AL, Doody DR, Wingo PA, McDonald JA, Malone KE, Folger SG, Spirtas R. Weiss LK, et al. Obstet Gynecol. 2002 Dec;100(6):1148-58. doi: 10.1016/s0029-7844(02)02502-4. Obstet Gynecol. 2002. PMID: 12468157

8

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR. Li CI, et al. JAMA. 2003 Jun 25;289(24):3254-63. doi: 10.1001/jama.289.24.3254. JAMA. 2003. PMID: 12824206

9

Oral contraceptives, tubal sterilization, and functional ovarian cyst risk.

Holt VL, Cushing-Haugen KL, Daling JR. Holt VL, et al. Obstet Gynecol. 2003 Aug;102(2):252-8. doi: 10.1016/s0029-7844(03)00572-6. Obstet Gynecol. 2003. PMID: 12907096

10

Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.

Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. Li CI, et al. Cancer. 2003 Oct 1;98(7):1504-13. doi: 10.1002/cncr.11663. Cancer. 2003. PMID: 14508839 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page